You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 126 No. 2, August 1970 TABLE OF CONTENTS
  Archives
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (73)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Reversible Bone Marrow Suppression From Chloramphenicol

A Consequence of Mitochondrial Injury

Adel A. Yunis, MD; Una S. Smith, PhD; Alberto Restrepo, MD

Arch Intern Med. 1970;126(2):272-275.


Abstract

Chloramphenicol is a potent inhibitor of mitochondrial protein synthesis. Recent studies on rabbit and human bone marrow mitochondria strongly suggest a relationship between inhibition of protein synthesis and myelotoxicity from chloramphenicol. A thorough electron microscopic study of bone marrow mitochondria derived from patients receiving chloramphenicol indicates that this drug induces ultrastructural modifications resulting in an increase in the density of the mitochondrial matrix. Excellent correlation is observed between the extent of the ultrastructural changes and serum levels of free chloramphenicol. The results lend further support to the hypothesis that reversible bone marrow suppression from chloramphenicol results from inhibition by the drug of mitochondrial protein synthesis.



Author Affiliations

Miami, Fla; Medellin, Colombia

From the Department of Medicine and Biochemistry and Howard Hughes Medical Institute, University of Miami School of Medicine, Miami, Fla (Drs. Yunis and Smith); and the Department of Medicine, University of Antioquia, Medellin, Colombia (Dr. Restrepo).


Footnotes

Received for publication Feb 9, 1970; accepted April 3.

Reprint requests to University of Miami, PO Box 875, Biscayne Annex, Miami, Fla 33152 (Dr. Yunis).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Erythroid dysplasia, megaloblastic anemia, and impaired lymphopoiesis arising from mitochondrial dysfunction
Chen et al.
Blood 2009;114:4045-4053.
ABSTRACT | FULL TEXT  

Ex vivo zidovudine (AZT) treatment of CD34+ bone marrow progenitors causes decreased steady state mitochondrial DNA (mtDNA) and increased lactate production
Lewis et al.
Hum Exp Toxicol 2004;23:173-185.
ABSTRACT  

Stratified Outcome Comparison of Clindamycin-Gentamicin vs Chloramphenicol-Gentamicin for Treatment of Intra-abdominal Sepsis
Lennard et al.
Arch Surg 1985;120:889-898.
ABSTRACT  

Vacuolization of Leukocytes and Bone Marrow Aplasia Due to Chloramphenicol Toxicity
Awwaad et al.
CLIN PEDIATR 1975;14:499-506.
 

Parenteral Clindamycin Therapy for Severe Anaerobic Infections
Chow et al.
Arch Intern Med 1974;134:78-82.
ABSTRACT  

Chloramphenicol-lnduced Bone Marrow Suppression
JAMA 1970;213:1183-1184.
ABSTRACT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1970 American Medical Association. All Rights Reserved.